Overview Meloxicam 15 mg Tablets Under Fasting Conditions Status: Completed Trial end date: 2004-02-01 Target enrollment: Participant gender: Summary The objective of this study is to compare the rate and extent of absorption of meloxicam from a test formulation Meloxicam 15 mg Tablets versus the reference Mobic® 15 mg Tablets under fasting conditions. Phase: Phase 1 Details Lead Sponsor: Teva Pharmaceuticals USATreatments: Meloxicam